Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

BioSpring, Dr. Reddy's, InteRNA Technologies, Quiet Therapeutics, Laboratory of Pharmacology and Toxicology (LPT) GmbH & Co. KG, VU University Medical Center ca

November 11, 2013 8:00 AM UTC

The MIRacle Consortium received a €1.2 million ($1.6 million) grant from the EU's Framework Programme 7 (FP7) to develop tumor-selective microRNA-based therapeutics to treat head and neck cancer. The ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article